The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 2 October 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 545K)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaeffer, E. M.
Right arrow Articles by Schwartzberg, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaeffer, E. M.
Right arrow Articles by Schwartzberg, P. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/10/987/ $5.00
The Journal of Experimental Medicine, Volume 192, Number 7, October 2, 2000 987-1000


Original Article

Tec Family Kinases Modulate Thresholds for Thymocyte Development and Selection

Edward M. Schaeffera,c, Christine Broussarda, Jayanta Debnatha, Stacie Andersona, Daniel W. McVicarb, and Pamela L. Schwartzberga
a National Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
b National Cancer Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
c Department of Pathology, University of Chicago, Chicago, Illinois 60637

Correspondence to: Pamela L. Schwartzberg, Bldg. 49/4A38, 49 Convent Dr., National Human Genome Research Institute, NIH, Bethesda, MD 20892-4472. Tel:301-435-1906 Fax:301-402-2170

Tec family kinases are implicated in T cell receptor (TCR) signaling, and combined mutation of inducible T cell kinase (Itk) and resting lymphocyte kinase (Rlk)/Txk in mice dramatically impairs mature T cell function. Nonetheless, mutation of these kinases still permits T cell development. While itk-/- mice exhibit mild reductions in T cells with decreased CD4/CD8 cell ratios, rlk-/-itk-/- mice have improved total T cell numbers yet maintain decreased CD4/CD8 ratios. Using TCR transgenics and an in vitro thymocyte deletion model, we demonstrate that mutation of Tec kinases causes graded defects in thymocyte selection, leading to a switch from negative to positive selection in rlk-/-itk-/- animals. The reduction in both positive and negative selection and decreased CD4/CD8 ratios correlates with decreased biochemical parameters of TCR signaling, specifically defects in capacitive Ca2+ influx and activation of the mitogen-activated kinases extracellular signal–regulated kinase 1 and 2. Thus, Tec kinases influence cell fate determination by modulating TCR signaling, leading to altered thresholds for thymocyte selection. These results provide support for a quantitative model for thymic development and provide evidence that defects in negative selection can substantially alter thymic cellularity.

Key Words: gene-targeted mice, signal transduction, Itk, Rlk/Txk, T cell receptor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS